Centaurus Financial Inc. Has $1.01 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Centaurus Financial Inc. cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,053 shares of the medical equipment provider’s stock after selling 624 shares during the quarter. Centaurus Financial Inc.’s holdings in Intuitive Surgical were worth $1,009,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of ISRG. Mirador Capital Partners LP raised its position in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares in the last quarter. Consolidated Planning Corp increased its holdings in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after buying an additional 76,649 shares during the period. Swiss National Bank boosted its holdings in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock worth $517,209,000 after buying an additional 3,400 shares in the last quarter. Finally, ABLE Financial Group LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $604,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares of the company’s stock, valued at $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,539 shares of company stock valued at $26,112,364. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $536.55 on Tuesday. The company has a market capitalization of $191.11 billion, a PE ratio of 86.26, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. The business has a fifty day moving average price of $505.63 and a two-hundred day moving average price of $465.19. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company upped their price target on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, BTIG Research set a $535.00 target price on Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.